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Summary 
Ca2+-calmodulin (CAM) function was selectively dis- 
rupted in a specific subset of growth cones in transgenic 
Drosophila embryos in which a specific enhancer ele- 
ment drives the expression of the kinesin motor do- 
main fused to a CaM antagonist peptide (kinesin-an- 
tagonist or KA, which blocks CaM binding to target 
proteins) or CaM itself (kinesin-CaM or KC, which acts 
as a Ca2+-binding protein). In both KA and KC mutant 
embryos, specific growth cones exhibit dosage-depen- 
dent stalls in axon extension and errors in axon guid- 
ance, including both defects in fasciculation and 
abnormal crossings of the midline. These results dem- 
onstrate an in vivo function for Ca2+-CaM signaling in 
growth cone extension and guidance and suggest that 
Ca2+-CaM may in part regulate specific growth cone 
decisions, including when to defasciculate and whether 
or not to cross the midline. 
Introduction 
During development, neuronal growth cones traverse a 
variety of terrains containing an array of both attractive 
and repulsive guidance molecules, including extracellular 
matrix components, cell adhesion molecules, and other 
cell surface ligands on neighboring cells and neurites, and 
chemoattractive or chemorepulsive cues secreted from 
more distal cells (reviewed by Goodman and Shatz, 1993; 
Goodman, 1994). Individual growth cones are presumably 
covered with a variety of different receptors that help them 
discriminate between these extracellular signals and 
transduce them into meaningful cytoplasmic signals that 
regulate growth cone motility, extension, and guidance, 
and ultimately, the transformation of the growth cone into 
a presynaptic terminal. 
Extensive in vitro assays have begun to reveal certain 
components of growth cone signal transduction machin- 
ery (e.g., Schuch et al., 1989; Doherty and Walsh, 1994). 
Nevertheless, little is known about what aspects of growth 
cone behavior in vivo are controlled by these signaling 
pathways. Moreover, given the recent discoveries of new 
families of guidance Signals (e.g., Kolodkin et al., 1992, 
1993; Luo et al., 1993; Serafini et al., 1994; Kennedy et 
al., 1994), we are still a long way from having a coherent 
picture of the range of downstream signaling systems 
within the growth cone and how they interact to govern 
growth cone behavior. 
Ca 2÷ has been implicated in the regulation of a wide 
range of growth cone behaviors (Kater and Mills, 1991; 
Cypher and Letourneau, 1992). For example, increases 
in internal Ca 2+ have been associated with axonogenesis 
(Silver et al., 1990; Bentley et al., 1991), axon turning 
(Zheng et al., 1994), specific growth cone contacts (Bent- 
ley et al., 1991), changes in filopodial morphology (Daven- 
port and Kater, 1992; Rehder and Kater, 1992), certain 
kinds of growth cone collapse in vitro (Bandtlow et al., 
1993), and cell adhesion molecule-mediated neurite out- 
growth in vitro (e.g., Doherty and Walsh, 1994). Although 
a few actin- or microtubule-binding proteins may interact 
directly with Ca 2÷ (Janmey, 1994; Lee, 1993), much of the 
Ca 2÷ signal is undoubtedly transduced by calmodulin 
(CAM), a major intracellular receptor for Ca 2÷ (e.g., Gnegy, 
1993; Hinrichsen, 1993). CaM, with over 20 target proteins 
known to be involved in cyclic nucleotide metabolism, en- 
ergy metabolism, secretion, and cytoskeletal dynamics, 
is well suited to be an important mediator of Ca 2+ signaling 
and regulator of growth cone behavior. Indeed, pharmaco- 
logical inhibitors of CaM can, for example, prevent the 
decrease in neurite outgrowth in response to increases in 
intracellular Ca 2÷ (Polak et ai., 1991). Overexpression of 
CaM-dependent protein kinase II (CaMKII), a major sub- 
strate for CaM (Hanson and Schulman, 1992), in cultured 
neuroblastoma cells results in increased neurite out- 
growth (Goshima et al., 1993). Thus, there is much circum- 
stantial evidence that Ca 2+ and its major intracellular e- 
ceptor, CaM, play important roles in growth cone signal 
transduction. However, in some respects, Ca 2+ signaling 
has been implicated in so many aspects of growth cone 
behavior that it is difficult o predict which of these behav- 
iors it really controls in vivo and which receptor systems 
transduce their signals via this pathway. 
One way to begin to elucidate the in vivo function(s) of 
Ca 2÷ signaling in growth cone behavior would be to perturb 
specifically this signal transduction pathway in particular 
growth cones in the developing embryo. Our goal in the 
present study has been to use the power of genetics in 
Drosophila melanogaster to target specifically the disrup- 
tion of Ca2+-CaM function in particular growth cones in 
the developing embryo. To this end, we used transposon- 
mediated transformation methods to generate transgenic 
fruitflies carrying transposons with control elements that 
drive the expression of specific fusion proteins in a defined 
subset of identified neurons; these fusion proteins are con- 
structed such that they will be targeted for the growth cone 
and will either block CaM binding to target proteins or CaM 
binding to Ca 2÷. 
The plethora of CaM-regulated events makes it difficult 
to use null mutations in the calmodulin gene to address 
the specific role of CaM in growth cone guidance (Doyle 
et al., 1990; K. Beckingham, personal communication). 
Moreover, the loading of the embryo with maternally de- 
rived CaM makes it difficult o conduct traditional loss-of- 
function genetic analysis of these events (Kovalick and 
Beckingham, 1992). We circumvented these problems by 
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Figure 1. Development of the vMP2 and MP1 
Pathways in Wild-Type versus KA and KC 
Stage 14 Mutant Embryos 
(A) Diagrams based on light and electron mi- 
croscopy of stage early 14 wild-type mbryos 
(Lin et al., 1994; R. Fetter et al., unpublished 
data). The circles show the size and location 
of the nuclei of identified neurons (MP1, dMP2, 
vMP2, SP1, pCC, and aCC) and gila (LGX). 
The lines and arrows how the locations of the 
axons and growth cones of these neurons at 
this stage. The vMP2 pathway is pioneered by 
pCC with vMP2 following close behind. The 
MP1 pathway ispioneered by dMP2, with MP1 
following close behind. For part of the distance 
within each segment, pCC and dMP2 fascicu- 
late to form the combined MP1 pathway. 
Around the middle of LGX, dMP2 defascicu- 
lates from pCC and forms the independent 
MP1 pathway. 
(B and C) When Ca2+-CaM signaling is dis- 
rupted in the MP1 pathway growth cones in 
KA and KC mutant embryos, we observe two 
classes of phenotypes at stage 14: stalls in 
axon extension at specific hoice point locations (B) and errors in axon guidance at specific hoice point locations (C). 
(B) In some segments, dMP2 stalls around the aCC initial axon segment (1), where normally itwould display only a transient affinity before turning 
posteriorly. In other segments, dMP2 extends posteriorly and then stalls around the LGX glial cell (2), where normally itwould defasciculate from 
pCC and continue xtending posteriorly to pioneer its own pathway. 
(C) In some segments, dMP2 continues to extend but fails to defasciculate properly from pCC at the LGX glial cell location, and instead, dMP2 
and MP1 extend more medially as they remain fasciculated inthe vMP2 pathway. 
designing two dominant inhibitors of CaM function and 
then expressing them using a specific enhancer element 
that drives expression in a set of well-characterized neu- 
rons (e.g., pCC, vMP2, dMP2, and MP1) whose axons 
pioneer two well-described axon pathways: the MP1 and 
vMP2 pathways (Hiromi et al., 1985; Doe et al., 1988). In 
addition, we targeted these CaM function inhibitors to the 
growth cone by using the motor domain of kinesin, a micro- 
tubule-dependent ATPase involved in fast axonal trans- 
port (Skoufias and Scholey, i993), kinesin has been used 
previously to target 13-galactosidase (13-gal) fusion proteins 
to the growth cone (Giniger et al., 1993). 
The interaction between CaM and some of its target 
enzymes, in particular smooth and skeletal muscle myosin 
light chain kinases (MLCKs), has been characterized in 
great detail (e.g., reviews by Means et al., 1991; Weinstein 
and Mehler, 1994). When CaM binds Ca 2+, it interacts with 
the basic amphipathic helix of the CaM-binding domain 
of a target enzyme and removes an overlapping auto- 
inhibitory domain from the catalytic site. The interactions 
between CaM and synthetic peptide analogs of this regula- 
tory domain have been studied extensively using enzy- 
matic (e.g., Bagchi et al., 1992; Bowman et ai., 1992; Gao 
et al., 1993; Persechini et al., 1994) and biophysical (e.g., 
Chattopadhyaya et al., 1992; Ikura et al., 1992; Knighton 
et al., 1992; Trewhela, 1992; Gough and Taylor, 1993) 
techniques; a crystal structure of this interaction is now 
available (Meador et al., 1992, 1993). Synthetic peptide 
analogs of this binding region are highly specific competi- 
tive inhibitors of CaM (ICs0 of about 1 nM) both in vitro 
(VanBerkum and Means, 1991) and in vivo (McCarron et 
al., 1992). 
We attached the CaM-binding domain of MLCK to the 
C-terminus of the motor domain of kinesin to create a fu- 
sion protein we term kinesin-antagonist (KA). KA should 
be targeted to the growth cone by kinesin-mediated micro- 
tubule transport and then function as a potent inhibitor of 
CaM in the growth cone. In principle, as the intracellular 
Ca 2+ levels rise in the growth cone (possibly in response 
to guidance cues), endogenous CaM will bind to Ca 2÷, KA 
will act as a functionless but potent CaM-binding protein, 
and thus much of the normal CaM-mediated signaling will 
be prevented. Similarly, a potent Ca2÷-binding protein was 
targeted to the growth cone by attaching chicken CaM to 
the C-terminus of the kinesin motor domain (kinesin-CaM 
[KC]). This protein competes with endogenous CaM or 
other Ca2+-binding proteins for available Ca 2÷. From avail- 
able structure-function studies on CaM and CaM activa- 
tion of target enzymes, owing to the location and size of 
the kinesin attachment, KC is predicted to be unable to 
activate CaM-dependent enzymes (Zot et al., 1990; Van- 
Berkum and Means, 1991; Persechini et al., 1994). 
To drive the expression of these fusion proteins, we used 
the fushitarazu (ftz) neurogenic (ftzng) control element (Hir- 
omi et al., 1985) because it has previously been shown 
to drive the expression of 13-gal (Doe et al., 1988) in a 
specific subset of identified neurons, including the pCC, 
vMP2, dMP2, and MP1 neurons, whose growth cones pio- 
neer the first two longitudinal axon pathways (the vMP2 
and MP1 pathways) and whose axon pathfinding has been 
studied in great detail (Lin et al., 1994). We assessed the 
role of Ca2+-CaM signaling in these growth cones by moni- 
toring their behavior and the formation of the MP1 and 
vMP2 pathways in KA or KC transformants. Expression 
of both KA and KC fusion proteins in stable transformants 
leads to dosage-dependent s alls in neurite extension, de- 
fects in fasciculation, and abnormal crossings of the mid- 
line. Transformants expressing just the kinesin motor do- 
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main or a kinesin-13-gal chimeric were indistinguishable 
from wild-type embryos. This study provides in vivo evi- 
dence that Ca 2÷ signaling in the growth cone is required for 
proper axon pathfinding. Moreover, these results suggest 
that Ca 2÷ may in part regulate certain growth cone deci- 
sions, including whether or not to cross the midline. 
Results 
Development of the vMP2 and MP1 Pathways 
The first two longitudinal axon pathways to form in the 
CNS of the Drosophila embryo are the vMP2 and MP1 
fascicles (Figure 1A). The formation of these pathways 
during stages 13-14 has been studied extensively using 
two different monoclonal antibodies (the 22C10 and 1D4 
anti-fasciclin II MAbs) in light microscopy and extensive 
electron microscopic serial section reconstructions (Lin et 
al., 1994; R. D. Fetter, C. Kopczynski, V. Auld, G. Grennin- 
gloh, and C. S. G., unpublished ata); the same two MAbs 
are used here to follow the development of these two path- 
ways in transgenic embryos in which Ca2+-CaM function 
is disrupted in specific vMP2 and MP1 pathway growth 
cones. 
In wild-type embryos at stage late 12, the pCC growth 
cone begins to extend anteriorly to pioneer the vMP2 path- 
way. The vMP2 growth cone then follows behind pCC and 
tightly fasciculates with pCC. The pCC growth cone contin- 
ues to extend anteriorly as it jogs laterally and internally 
toward the cell body of the SP1 neuron and a specific glial 
cell called LGX. pCC's growth cone extends along the 
medial surface of LGX. pCC and vMP2 adhere to each 
other and to LGX, with vMP2 being more medial and also 
adhering to the SP1 cell body. About this time, the dMP2 
growth cone extends laterally along the aCC axon and 
then turns posteriorly. The M P1 growth cone tightly fascic- 
ulates with dM P2 and extends behind it. When the posteri- 
orly extending dMP2 growth cone meets the anteriorly 
extending pCC growth cone at stage late 13, they tightly 
fasciculate together, forming the combined MP1 pathway. 
Once the dMP2 growth cone has reached the next poste- 
rior segment, at a specific location (Figure 1A) it abruptly 
defasciculates from pCC at stage mid 13. Rather than 
extending along the more medial vMP2 pathway, it instead 
extends posteriorly in a more lateral location to pioneer 
the MP1 pathway, which is complete by stage early 14. 
In this way, two pathways form within each segment: the 
vMP2 and the MP1 fascicles. Between the segments, 
these two pathways are fused in the combined MP1 path- 
way (Figure 1A). 
Using the ftz.g Element and the kinesin Motor 
Domain to Drive Fusion Proteins into the 
Growth Cones of Specific Neurons 
We used the ftzng control element (Hiromi et al., 1985), a 
well-characterized 1.4 kb piece of genomic DNA from the 
5' flanking region of the ftz gene, to drive the expression 
of CaM inhibitors in a subset of CNS neurons, including 
those (pCC, vMP2, dMP2, and MP1) whose axons pioneer 
the vMP2 and MP1 pathways. Based on the expression 
pattern of the ftzng element (Doe et al., 1988), we suspected 
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Figure 2. Minigene Constructs Encoding Fusion Proteins Used to Ex- 
amine Ca2÷-CaM Signaling in the Growth Cone 
We used the ftzng control element to drive the expression of five differ- 
ent minigenes in the neurons whose axons pioneer the vMP2 and 
MP1 pathways (pCC, vMP2, dMP2, and MP1). Ca2÷-CaM signaling in 
the growth cone was selectively inhibited using the kinesin motor do- 
main to drive a CaM antagonist peptide (1) or CaM itself (2) into the 
growth cone. A kinesin-antagonist (KA) protein was created by remov- 
ing the CaM regulatory domain (plus flanking sequences) from MLCK 
and attaching itto the C-terminus of the kinesin motor domain (1). KA 
will compete with other CaM target proteins for Ca2*-CaM and thus 
prevent much of the CaM-mediated signaling in the growth cones of 
these neurons. A second kinesin fusion protein was created by at- 
taching a wild-type chicken CaM to the C-terminus of the motor domain 
of kinesin to create kinesin-CaM (KC), a Ca2÷-binding protein (2). KC 
should inhibit CaM (and other Ca2+-binding proteins) by competing for 
available Ca 2÷. The third minigene (3) encodes just the kinesin motor 
domain (K); the fourth rninigene (4) encodes kinesin attached to 13-gal 
(KI3G). These two proteins (3 and 4) serve as controls to ensure that 
the kinesin portion of KA or KC is not responsible for the altered growth 
cone behavior. Finally, to test whether the CaM binding antagonist 
peptide needs to be translocated tothe growth cone in order to exert 
its effect on growth cone behavior, the fifth minigene (5) encodes just 
the CaM-binding domain of MLCK (A; the same portion as used in 
KA)~ Without he kinesin motor domain, this CaM-binding peptide is 
expected to be distributed iffusely in the cell body and processes. 
that this regulatory element might allow us to manipulate 
Ca 2÷ signaling in these same growth cones and thus ana- 
lyze the resulting defects in axon pathfinding. Recent stud- 
ies have shown that ftzng transgenes drive fasciclin II ex- 
pression on the growth cones and axons of pCC, vMP2, 
dMP2, and MP1 at stages 13-14 (Lin et al., 1994). The 
ftzng element also drives expression of fasciclin II on the 
axons in the FN3 pathway, which can be visualized at 
stage 16 using the 1D4 MAb. 
Thus, we used the ftzng element o drive the expression 
of five different minigenes (Figure 2) in the neurons whose 
axons pioneer the vMP2 and MP1 pathways (pCC, vMP2, 
Neuron 
46 
A C~ - Kinesin 
O 
Kinesin 
- -  97.4 
KC 
KA 
--69 
~46 
- -  30  
B 
200 - -  
97,4 - -  
c~-~3-gal 
(.9 
• KpG 
C i. Ant ibody  ii. Ca ++ iii. EDTA 
- -  97 .4  
KA >- " 'P  > '~ 
- -  69 
- -  46  
Figure 3. Biochemical Characterization f Fu- 
sion Proteins 
(A) kinesin fusion proteins were co-pelleted 
with microtubules and identified by Western 
blot techniques using an anti-kinesin antibody. 
Native kinesin (115 kDa) is present in all lanes. 
The KA and KC fusion proteins (arrowheads) 
are present only in the KA and KC transgenic 
lines, respectively. The protein present in all 
lanes at variable amounts at - 97 kDa probably 
represents a degradation product of native 
kinesin. The protein at - 62 kDa is consistently 
present only in extracts from the KC166A line. 
The protein at - 49 kDa is background staining 
of tubulin. The blot was cut at the dotted line, 
and each portion was probed separately and 
developed for 10 s (top) or 10 min (bottom). 
WT, wild type; KA16B, KA26A, KC168A, and 
KC166A: different KA and KC transgenic lines, 
respectively. 
(B) Same as in (A), but using an antibody 
against ~-gal. Lower band is native kinesin de- 
tected by anti-kinesin that had not been com- 
pletely stripped off of the blot. K~G, kinesin- 
I~-gal. 
(C) In the left pair of KA16B versus WT blots 
(i), KA (arrowhead) is the sole protein recognized byan antibody raised against the CaM-binding domain of KA. In the middle and right pair of 
blots (ii and iii), only the KA protein (arrowhead) binds CaM in a Ca2+-dependent manner, as detected in this CaM overlay assay. The other bands 
represent nonspecific electrostatic interactions with either CaM or the HRP-conjugated Streptavidin used in this assay. Positions of the molecular 
mass standard in kilodaltons are indicated in all panels. 
dMP2, and MP1). We monitored the consequence of ex- 
pressing these fusion proteins on growth cone guidance 
using the 22C10 and 1 D4 MAbs. It is experimentally possi- 
ble to target hese proteins into the growth cone selectively 
using the kinesin motor domain (Giniger et al., 1993). 
When the ftz,g element was used to drive the expression of 
the axon marker kinesin-13-gal (KI3G; Giniger et al., 1993), 
consisting of the motor domain of kinesin fused to the lacZ 
gene, 13-gal activity at stage 13 was observed primarily in 
the growth cones of the dMP2 and vMP2 neurons (D. Van 
Vactor, personal communication). 
In the first two minigenes, Ca2+-CaM signaling in the 
growth cone was selectively inhibited by using the kinesin 
motor domain to drive a CaM antagonist peptide or CaM 
itself into the growth cone. A KA protein was created by 
removing the CaM regulatory domain (plus flanking se- 
quences) from the chicken MLCK (see Introduction for 
rationale) and attaching it to the C-terminus of the kinesin 
motor domain (Figure 2). KA will compete with other CaM 
target proteins for Ca2+-CaM, and thus prevent much of 
the CaM-mediated signaling in the growth cones of these 
neurons. A second kinesin fusion protein was created by 
attaching a wild-type chicken CaM to the C-terminus of 
the motor domain of kinesin to create KC, a Ca2+-binding 
protein. KC should inhibit CaM (and other Ca2+-binding 
proteins) by competing for available Ca 2+. It is predicted 
from structure-function studies that KC should not acti- 
vate CaM target proteins directly (see Introduction). 
The third minigene encodes just the kinesin motor do- 
main (K); the fourth minigene (D. Van Vactor, unpublished 
data) encodes kinesin attached to ~-gal (KI3G). These two 
proteins erve as controls to ensure that the kinesin portion 
of KA or KC is not responsible for the altered growth cone 
behavior. In addition, since K has an extra 35 amino acids 
attached to kinesin, it serves as a random peptide control 
for CaM antagonist activity. Finally, to test whether the 
CaM-binding antagonist peptide needs to be translocated 
to the growth cone in order to exert its effect on growth 
cone behavior, a fifth minigene gene (A) was constructed 
that encodes just the CaM-binding domain of MLCK (the 
same portion used in KA). Without the kinesin motor do- 
main, this CaM-binding peptide is expected to be distrib- 
uted diffusely in the cell body and processes (and thus 
reduce the concentration in the growth cone by at least 
10-fold). In all, 11 KA, 8 KC, 7 K, and 9 A independent 
transformant lines were isolated and maintained as bal- 
anced stocks; 1 previously made K~G line was also used. 
Biochemical Characterization of Fusion Proteins 
It was important o test to what extent the individual do- 
mains retained their biochemical properties in the context 
of these fusion proteins. First, we tested whether the KA, 
KC, and K~G fusion proteins would still bind microtubules 
(as does Kinesin on its own) by determining whether they 
were co-pelleted with microtubules in embryo extracts 
(Saxton et al., 1988). Indeed, Western blots revealed that 
Kinesin as well as the KA, KC, and K~G fusion proteins 
were enriched by these procedures (Figures 3A and 3B). 
KA and KC can also be released from microtubules with 
excess ATP (data not shown). Thus, the microtubule- 
binding and ATPase-dependent activity of the kinesin mo- 
tor domain appears to be functional in these fusion pro- 
teins. 
Second, we used a CaM overlay assay to show that 
chicken CaM binds to KA in a Ca2+-dependent fashion in 
extracts enriched for KA by co-sedimentation with poly- 
merizecl microtubules (Figure 3C). That this protein is KA 
is demonstrated by its ability to bind to the rat antibody 
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Figure 4. Expression of KA Fusion Protein in 
MP1 Pathway Growth Cones 
Photographs of stage late 13 wild-type (A) or 
KA16B (B) embryos tained with either MAb 
22C10 (A), which most darkly stains the dMP2 
(white arrowhead) and vMP2 (white arrow) 
growth cones and axons, or MAb 10F4 (B), 
which recognizes the CaM-binding region of 
KA. At this stage (B), the KA fusion protein is 
clearly detected in the growth cones of dMP2 
(white arrowhead), vMP2 (white arrow), and 
pCC (black arrow); the growth cones are 
stained much more darkly than are the axons, 
confirming that the kinesin motor domain has 
driven the fusion protein down into the growth 
cones. Different focal planes were combined 
digitally in this panel. 
raised against the CaM-binding peptide (Figure 3C) and 
anti-kinesin antibodies (Figure 3A). Drosophila CaM, 
which differs from chicken CaM by only 3 out of 148 amino 
acids, activates chicken smooth muscle MLCK (from 
which the CaM-binding domain of KA was obtained) with 
kinetics identical to those of chicken CaM (Gao et al., 
1993), and thus should also bind KA. 
From the data on Ca 2÷ binding to CaM, including the 
conformational changes upon Ca 2÷ binding and the co- 
operativity of Ca 2÷ binding, it is anticipated that KC should 
retain the Ca2÷-binding properties of CaM. Indeed, like na- 
tive CaM, a bacterially expressed version of KC binds to 
phenyI-Sepharose in a Ca2÷-dependent fashion (data not 
shown). KC should thus bind up to four Ca 2÷ ions at approx- 
imately 1 ~M affinity (e.g., Beckingham, 1991). 
The Expression of KA In Vivo 
The biochemistry data suggest that these kinesin fusion 
proteins should be localized to the growth cone of the 
ftzng-expressing neurons by the translocation activity of 
kinesin. To confirm this putative growth cone localization, 
we used MAb 10F4, raised against the antagonist peptide 
(Figure 3C), to examine the localization of KA (Figure 4B). 
The 10F4 MAb recognized a peptide expressed in the ap- 
propriate ftzng pattern in KA transformant embryos but not 
wild-type controls. The ftzng enhancer element drives the 
expression of KA beginning at the end of stage 11 and 
continuing throughout embryogenesis, albeit at lower lev- 
els later in development. KA is present in the previously 
characterized segmentally repeating band of ftzng-express- 
ing neurons (Doe et al., 1988; Lin et al., 1994). These 
neurons include aCC, pCC, vMP2, dMP2, and MP1 neu- 
rons, as well as some of the RP motoneurons, a number of 
other motoneurons, and other unidentified interneurons, 
some of whose axons fasciculate in the FN3 pathway. 
Most important for this study, KA is present in the growth 
cones of the pCC, vMP2, dMP2, and MP1 neurons, the 
pioneers of the vMP2 and MP1 pathways, during stages 
12-14 (Figure 4B). In general, vMP2 and pCC exhibit he 
highest levels of expression at stage 13 as compared with 
dMP2, MP1, and aCC; however, considerable variability 
in the relative levels of expression is observed both within 
and between different embryos. In KI3G transformants, 
13-gal activity was also concentrated in the growth cones 
of these same neurons; the relative levels of KISG appear 
higher in dMP2 and vMP2 growth cones as compared with 
pCC and vM P2 growth cones at stage 13 (data not shown). 
As development proceeds, the ftzng element remains ac- 
tive, although at reduced levels; however, KA expression 
is still observed in the same segmentally repeated pattern 
of neurons. In a previous study (Lin et al., 1994), the axon 
projections of many of these neurons were followed using 
the same ftzng element o drive the expression of an axon 
marker, tau-15-gal (Callahan and Thomas, 1994). By stage 
16, most of the ftzng-expressing neurons extend their axons 
in the vMP2, MP1, or FN3 pathways. This is consistent 
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Figure 5. Stalls in Axon Extension and Errors in Growth Cone Guidance in KA and KC Mutant Embryos 
Photographs of stage early 14 wild-type (A), KA (B and C), and KC (D) embryos stained with MAb 22C10, which reveals the axons and growth 
cones in the vMP2 and MP1 pathways. In wild-type mbryos (A), the combined MP1 pathway between segments separates into two separate 
pathways within each segment: the more medial vMP2 pathway (white arrows pointing from left) and the more lateral MP1 pathway (white arrows 
pointing from right). Embryos homozygous for the KA (B and C) or KC (D) inserts display two classes of mutant phenotypes: stalls in axon extension 
and errors in axon guidance. Stalls in dMP2 extension are marked by the white arrowheads (B-D); stalls in vMP2 extension are marked by the 
white arrows (B and D). The absence of the MP1 pathway is marked by the white brackets in (B) and (D). In some segments, the dMP2 growth 
cone fails to defasciculate from pCC and instead continues to extend medially and posteriorly along the vMP2 pathway (short white arrows in 
[C]). See text for further details. Bar, 10 ~_m. 
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Table 1. Absence of MP1 Pathway in Embryos at Stages 13-14 
Transgenic Animals 
[# abnormal hemisegments/total # hemisegments (%)] 
Line Heterozygous Homozygous a Transheterozygous 
KA16B b 17/72 (24%) 147/182 (81%) 
KA26A 15/218 (7%) 176/332 (53%) 
KA61A 311190 (16%) 781128 (61%) 
KA16c ND c 110/212 (52%) 
KC137A 29/155 (19%) 105/194 (54%) 
KC163A ND 21/179 (12%) 
KC168A 5/32 (16%) 81/158 (51%) 
K14A ND 21180 (1%) 
K21 g N D 1/128 (0.8%) 
K103a N D 1/148 (0.7%) 
KI3G ND 0•274 (0%) 
KA16B x KC137A 
KA16B x KC168A 
Wild type d 11292 (0.3%) 
136/216 (63%) 
146/184 (79%) 
Homozygous embryos were identified by the absence of ~-gal staining as driven by a lacZ transgene on the balancer chromosome ( xcept wild 
type; see below). 
b Line KA16B has two copies of the KA P element inserted on the second chromosome. Thus, embryos have either two or four copies in heterozygous 
and homozygous embryos, respectively. 
c ND, not determined. 
d Wild-type, homozygous embryos (not transgenic) are w ~'e, the parental strain from which all other transgenic strains were derived. 
with the patches of KA staining observed with MAb 10F4 
along the MP1 and FN3 pathways at later stages (data 
not shown). 
MAb 10F4 should also recognize the CaM-binding pep- 
tide expressed in the A transformant lines. However, we 
were unable to observe the expression of this peptide with 
histological methods. This may be due to poor or diffuse 
expression, fast tu mover of the peptide in vivo, or technical 
difficulties in detecting such a small basic peptide. The 
CaM-binding peptide is arginine- and lysine-rich (see Ex- 
perimental Procedures for sequence) and could be readily 
targeted for degradation; in addition, the predicted diffuse 
intracellular distribution would increase the difficulty of im- 
munocytochemical observation of this peptide. 
The vMP2 and MP1 Pathway Growth Cones Show 
Specific Defects in Extension and Guidance 
When Ca2+-CaM Signaling Is Disrupted 
We used MAbs 22C10 and 1D4 to examine the develop- 
ment of the vMP2 and MP1 pathways during stages 13- 
14. Embryos from the 1 KI3G, 7 K, and 9 A transformant 
lines were indistinguishable from wild-type embryos (Fig- 
ure 5A; our wild-type embryos were w ~'8, the parental 
strain from which all of the transgenic strains were de- 
rived). However, the embryos from all 11 KA and 8 KC 
transformant lines exhibited defects in the formation of 
these first two longitudinal axon pathways. We analyzed 
the pathfinding errors in greater detail in 3 KA and 3 KC 
lines. These lines were all homozygous viable, and thus 
the phenotypic effects resulting from any potential gene 
disruption at the site of the transposon insertion are ex- 
pected to be minimal. No abnormal changes in neural cell 
fate or increases in cell death were observed in KA em- 
bryos stained with antibodies against the segmentation 
genes engrailed and even skipped. The 6 different rans- 
formant lines exhibited the same spectrum of pathfinding 
errors, although the severity of the phenotypes was more 
pronounced in KA lines. The following description applies 
to both KA (Figures 5B and 5C) and KC (Figure 5D) lines. 
Embryos homozygous for the KA or KC inserts display 
two classes of mutant phenotypes at stages 13-14: stalls 
in axon extension and errors in axon guidance. The initial 
outgrowth and orientation of the dMP2 and vMP2 growth 
cones at stage 12 appear relatively normal as assayed 
with MAb 22C10; this is a stage at which these growth 
cones are already expressing KA, and we presume KC 
as well. However, by mid stage 13, the first phenotype (the 
stall in growth cone extension) becomes quite pronounced 
for dMP2 and vMP2 in many segments (Figures 5B and 
5D; summarized in Figure 1B). 
This stalled extension phenotype is often transient. 
Many segments at stage early 14 exhibit stalls in dMP2 
and/or vMP2 extension. In some cases, stalls (i.e., gaps 
in the vMP2 and MP1 pathways) are still evident at stage 
16, the oldest embryos we have examined. During stages 
13-14, the dM P2 growth cone typically stalls in one of two 
locations. In many segments, dMP2 remains in extensive 
contact with the aCC cell body or initial axon segment and 
does not turn and extend posteriorly (Figures 5B and 5D; 
summarized in Figure 1 B, #1); it fails to defasciculate from 
aCC, a contact that in wild type is quite transient. In other 
segments, dMP2 remains adjacent to SP1 and LGX (Fig- 
ures 5B and 5D; summarized in Figure 1B, #2). Similarly, 
the vMP2's growth cone (and pCC as assayed with MAb 
1 D4) stalls in the region of its specialized contact with SP1 
(or perhaps the unstained LGX glial cell just lateral to SP1; 
summarized in Figure 1B). The rate of extension of aCC 
into the periphery is also sometimes talled in KA and KC 
lines compared with wild-type embryos. 
The second major phenotype, errors in axon guidance 
(summarized in Figure 1C), is first seen at stage late 13 
and becomes quite pronounced by stage early 14. In KA 
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and KC homozygous embryos, at the location in the middle 
of LGX where dMP2 normally defasciculates from pCC to 
pioneer the separate MP1 pathway (Figure 1A), instead 
we often observe that dMP2 fails to defasciculate from 
pCC and continues to extend along the vMP2 pathway, 
and thus only one axon pathway forms (Figure 5C; summa- 
rized in Figure 1C). Thus, the dMP2 and MP1 growth cones 
turn more medially than would normally occur in wild type 
and extend closer to the midline as they follow the vMP2 
pathway. 
At stages 13-14, the MP1 pathway appeared normal in 
the 1 KI3G and 7 K lines, whereas abnormalities were seen 
in every homozygous embryo from all 11 KA and 8 KC 
lines. We quantified the penetrance of the MP1 pathway 
phenotype at stages 13-14 by counting the number of 
hemisegments in which the MP1 pathway between the 
segments had not formed in embryos from 4 KA, 3 KC, 
1 K~G, and 3 K transformant lines (Table 1). The pene- 
trance of the MP1 pathway mutant phenotype in the 4 KA 
and 3 KC lines ranged from 12% to 81% of hemisegments 
for homozygotes and 7%-24% for heterozygotes. Homo- 
zygous embryos of any 1 KA or KC line have at least a 
3-fold higher penetrance of phenotype than the respective 
heterozygous embryos. KA line 16B as homozygotes 
showed the most penetrant phenotype (81%). This line 
contains two independent P-element inserts on the same 
chromosome, and thus the homozygotes contain four cop- 
ies of the KA gene. 
The KA and KC fusion proteins appear to be able to 
act cooperatively in increasing the penetrance of these 
phenotypes, further suggesting that they are both interfer- 
ing with the same signaling process. Transheterozygote 
embryos carrying two copies of KA (i.e., line KA16B) and 
one copy of KC (KC137A or KC168A) show a higher per- 
centage of abnormal hemisegments than the sum of both 
lines alone. We observed MP1 pathway abnormalities in 
63%-79% of hemisegments in these transheterozygous 
embryos as compared with 24% for KA16B, 19% for 
KC137A, and 16% for KC168A heterozygous embryos 
(Table 1). 
The MP1 Pathway Axons Abnormally Cross 
the Midline When Ca=+-CaM Signaling Is 
Disrupted in Their Growth Cones 
After stage early 14, it becomes increasingly difficult with 
the available probes (MAbs 22C10 and 1D4) to distinguish 
individual growth cones. However, from this time on, we 
can observe the trajectories of specific axon pathways and 
the behavior of axons that normally fasciculate tightly in 
these pathways using MAb 1D4 to stain the axons in the 
vMP2, MP1, and FN3 pathways (Lin et al., 1994). The 
most striking KA and KC mutant phenotype is that in many 
segments the MP1 pathway freely crosses the midline 
(Figures 6B-6D; summarized in Figure 7B). The cross- 
overs tend to take place in the region around the posterior 
commissure or between the two commissures. In some 
segments, there is only a single MP1 pathway on one side 
of the segment (Figure 6B; the contralateral MP1 pathway 
having crossed over in a neighboring segment), whereas 
in other segments, disrupted MP1 pathways are observed 
on both sides of the midline (Figures 6C and 6D). More- 
over, we occasionally see FN3 pathway axons cross the 
midline as well (Figure 6B). In some respects, this mutant 
phenotype at stage 16 is reminiscent of the MP1 pathway 
midline crossovers observed in embryos mutant for the 
roundabout (robo) gene (Seeger et al., 1993). 
In wild-type embryos, the MP1 pathway never crosses 
the midline. Clearly, in KA and KC homozygous mutant 
embryos, the axons in the MP1 pathway no longer respect 
this midline boundary and instead freely cross the midline. 
We do not know which MP1 pathway growth cone(s) is 
the first to cross the midline. The dMP2 and MP1 growth 
cones are good candidates. They remain abnormally fas- 
ciculated with the vMP2 pathway at stage 13 and by stage 
early 14 extend much closer to the midline than would 
normally occur. It is possible that in some segments these 
growth cones might cross the midline around the posterior 
commissure, where they are only a short distance from 
their contralateral homologs. Alternatively, itcould be that 
subsequent follower growth cones that also express KA 
are the first to cross the midline at this location. Regardless 
of which axons are the first to cross, it appears that all of 
the MP1 pathway axons are capable of crossing the mid- 
line and do so repeatedly in multiple segments in KA and 
KC lines. 
The final phenotype observed in these KA and KC stage 
16 mutant embryos is that axons do not remain as tightly 
fasciculated in the specific MP1 and FN3 pathways. 
Rather, axons are observed to wander in and out of any 
given pathway; in some cases, whole bundles of axons 
shift from one pathway to another (Figure 6B). Both of 
these phenotypes correlate with the observation that the 
ftz,g element drives expression in most if not all of the 
axons in the MP1 and FN3 pathways (Lin et al., 1994). 
Discussion 
Growth cones can detect and discriminate between a wide 
variety of different ypes of guidance cues. How many of 
these guidance cues are transduced through Ca2+-de - 
pendent signaling mechanisms is unknown. To study di- 
rectly the role of CaM signaling in transducing rowth cone 
guidance cues in vivo, we designed a system that selec- 
tively disrupts Ca2+-CaM function in specific growth cones 
in the developing organism. To this end, we combined 
the power of genetics in Drosophila with the ability to use 
specific antibody probes to follow the growth cones that 
normally pioneer the first two longitudinal axon pathways, 
the vMP2 and MP1 pathways, and the subsequent rajec- 
tories of these axon pathways. Much is already known 
about the behavior of these growth cones and the develop- 
ment of these pathways (e.g., Lin et al., 1994; Fetter et 
ai., unpublished ata), and thus we should be able to de- 
tect even subtle defects in growth cone behavior. By spe- 
cifically disrupting Ca2+-CaM signaling in these growth 
cones in vivo, we have shown that Ca2÷-CaM signaling 
plays an important role in the events of growth cone exten- 
sion and guidance. 
We created minigenes that encode novel proteins de- 
signed to inhibit Ca 2÷ or CaM signaling in the growth cone 
Ca2÷-calmodulin Signaling in the Growth Cone 
51 
Figure 6. The MP1 Pathway Abnormally Crosses the Midline in KA and KC Mutant Embryos 
Photographs of stage 16 wild-type (A), KA (B and C), and KC (D) embryos stained with MAb 1D4 (anti-fasciclin II). 
(A) In wild-type embryos, MAb 1D4 reveals the axons in three distinct longitudinal pathways, including the MP1 pathway (white arrow with thin 
shaft), the FN3 pathway (white arrow with thick shaft), and another more lateral pathway. 
(B-D) The most striking KA and KC mutant phenotype is that in many segments the MP1 pathway freely crosses the midline (feathered white 
arrow in [C]). The crossovers tend to take place in the region around the posterior commissure, or between the two commissures. In some segments, 
there is only a single MP1 pathway on one side of the segment (B), whereas in other segments, disrupted MP1 pathways are observed on both 
sides of the midline (C and D). We occasionally see FN3 pathway axons cross the midline (B). Bar, 10 i~m. 
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Figure 7. Summary of MP1 Pathway Phenotypes in KA and KC Stage 
16 Mutant Embryos 
Summary diagram showing the pattern of MAb 1D4 (anti-fasciclin II) 
staining of three prominent longitudinal axon pathways in wild-type 
(A) versus KA and KC (B) stage 16 embryos. The most striking and 
consistent phenotype observed in KA and KC mutant embryos at this 
stage is the MP1 pathway abnormally crossing the midline in multiple 
segments. See text for further discussion. AC, anterior commissure; 
PC, posterior commissure. 
and used a specific enhancer element (the ftz.g element; 
Hiromi et al., 1985) to express these fusion proteins in the 
neurons whose axons pioneer the vMP2 and MP1 path- 
ways. We used the motor domain of kinesin (Giniger et 
al., 1993) to target these fusion proteins for the growth 
cone. The fusion proteins were designed to block CaM 
function by targeting to the growth cone either a CaM an- 
tagonist peptide (the KA construct) or a Ca2+-binding pro- 
tein in the form of a kinesin fusion protein version of CaM 
(the KC construct). 
Both the KA and KC minigenes led to dramatic mutant 
phenotypes that were strikingly similar in their defects, 
dose-dependent in tt~eir penetrance, and cooperative in 
their action. At stages 13-14, when we could monitor the 
behavior of four individual identified growth cones (pCC, 
vMP2, dMP2, and MP1) that all express KA and presum- 
ably KC as well, we observed two major mutant pheno- 
types: stalls in axon extension (often at specific choice 
points) and errors in axon guidance (also often at specific 
choice points). At stage 16, when we could observe the 
trajectory of two major longitudinal axon pathways (the 
MP1 and FN3 pathways) and the axons that normally fas- 
ciculate in them, we observed two major phenotypes: the 
MP1 pathway no longer respects the midline boundary 
and instead freely crosses the midline, and axons that 
would normally fasciculate faithfully in one particular path- 
way instead wander from one pathway to another. All of 
these phenotypes were observed in multiple independent 
KA and KC lines. In contrast, we observed the normal 
behavior of the vMP2 and MP1 growth cones at stages 
13-14, and the normal trajectory of the MP1 pathway at 
stage 16 in control embryos expressing either the kinesin 
motor domain alone (K), the kinesin-13-gal construct (KI3G), 
or the antagonist peptide alone (A). Thus, it appears on 
the one hand that it is not the kinesin domain alone that 
causes the mutant phenotypes, and yet on the other hand, 
the kinesin domain is necessary to target these Ca2÷-CaM 
inhibitors to the growth cone in order to observe these 
phenotypes. 
The in vivo defects in growth cone behavior and axon 
pathway trajectory observed in the KA and KC mutants 
suggest that Ca2+-CaM signaling in the growth cone is 
required both for regulating axon extension, particularly at 
certain choice points, and for transducing critical guidance 
information, including whether to defasciculate at specific 
choice points and whether to cross the midline. It is striking 
that both the KA and KC transformants display similar 
phenotypes, and that transheterozygous embryos con- 
taining copies of both KA and KC inserts show enhanced 
penetrance of these phenotypes. KA can only inhibit CaM 
function, whereas KC could in principle function in several 
different fashions, including either the inhibition or en- 
hancement of CaM function. For the latter to occur, KC 
would have to function by providing additional functional 
CaM in the growth cone. Arguing against this possibility 
are the observations that KC lines show the same mutant 
phenotypes as do KA lines, that these phenotypes are 
displayed with equal penetrance, and most importantly, 
that KC and KA cooperatively enhance each other in trans- 
heterozygous mutant embryos. Were KC to enhance 
rather than inhibit CaM function, it would be expected to 
suppress rather than enhance the KA mutant phenotype. 
Our data are more consistent with models in which KC 
functions as a dominant inhibitor of CaM function. The 
similarity in phenotype and penetrance of KC and KA sug- 
gests that the major route for Ca 2+ signaling in the growth 
cone operates via CaM function. The dominant inhibitory 
function of KC could occur in either of two ways: by binding 
Ca 2+ and thus inhibiting the activation of CaM, or by bind- 
ing to CaM target proteins but failing to activate them. The 
first model for KC action is consistent with the body of CaM 
structure-function evidence (e.g., Beckingham, 1991) and 
the ability of KC to bind phenyI-Sepharose in a Ca 2+- 
dependent manner. Studies on CaM activation of target 
proteins (e.g., MLCK or CaMKII) predict that the globular 
Kinesin domain ( -  600 amino acids) should sterically hin- 
der KC activation of CaM-dependent enzymes. However, 
the second model for KC action as a dominant inhibitor 
Js also possible. Mutagenesis of CaM indicates that CaM 
has different structural requirements for binding to versus 
activation of various target proteins (Zot et al., 1990; Van- 
Berkum and Means, 1991; Persechini et al., 1994). In ei- 
ther case, KC appears to block Ca2+-CaM function in the 
growth cone in a fashion very similar to KA. It is satisfying 
that these two proteins (KA and KC) provide two different 
ways of interfering with Ca2+-CaM function and both give 
rise to identical mutant phenotypes. These results suggest 
that, in the growth cone, CaM is a major downstream el- 
lector of Ca 2+ signaling, although other CaM-independent 
pathways cannot be ruled out. 
Disrupting Ca 2+ signaling in the pCC, vMP2, dMP2, and 
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MP1 growth cones leads to stalls in axon extension and 
errors in axon guidance, including the failure to defascicu- 
late at a specific choice point. Are the stalls in extension 
related to the errors in guidance, or are they two indepen- 
dent functions? When specific growth cones are stalled, 
the stalls tend to occur at locations where these growth 
cones normally display a transient affinity for some particu- 
lar cell surface, and then detach as they turn and extend 
in another direction. For example, the dMP2 growth cone 
stalls where it contacts the aCC axon (Figure 1B, #1) or 
where it contacts the LGX glial cell (Figure 1B, #2). Simi- 
larly, pCC and vMP2 stall where they contact the SP1 
neuron or LGX glial cell. 
These stalls in axon extension could be due to a defect in 
the motility apparatus. Alternatively, the stalls could result 
from a failure to respond properly to the next sequential 
guidance cue and/or their inability to detach or defascicu- 
late from what should have been a transient contact. Argu- 
ments can be put forward for both explanations. For exam- 
ple, overexpression of CaMKII (a major target enzyme for 
CaM) in neuroblasts results in increased neurite outgrowth 
(Goshima et al., 1993). Thus, a reduction in CaM function 
in KA and KC transformants might inhibit axon extension. 
Alternatively, Ca 2÷ signaling might be required to detach 
a growth cone from one guidance substrate, thereby 
allowing it to respond to new guidance cues. CaM regula- 
tion of calcineurin, a CaM-dependent phosphatase, has 
been implicated in the regulation of neutrophil migration. 
In these neutrophils, injection of calcineurin inhibitor pep- 
tides appears to prevent the release of cells from attach- 
ment sites by inhibiting the dephosphorylation of integrin 
(Hendey et al., 1992). Perhaps neural cell adhesion mole- 
cules can also be reversibly regulated by Ca2÷-CaM -
dependent mechanisms. 
The growth cone stalls we observe in KA and KC em- 
bryos are not necessarily related directly to deficits in the 
motility apparatus. The initial events of neurite outgrowth 
occur normally in these mutants (even though KA is ex- 
pressed at this stage), and the locations of the stalls are 
relatively consistent and tend to occur at major choice 
points, where axon pathways intersect or where growth 
cones make major changes in their trajectory. The speci- 
ficity of the locations of these stalls suggests that the de- 
creases in Ca 2+ signaling in KA and KC mutants may ham- 
per the ability of the growth cone to transduce new 
guidance cues or to change from one substrate to another. 
Extensive in vitro analysis has shown that neural cell adhe- 
sion molecule-mediated neurite outgrowth requires Ca 2+ 
signaling (e.g., Doherty and Walsh, 1994). Perhaps in KA 
and KC mutants, cell adhesion molecule-mediated guid- 
ance cues (or other types of guidance cues) can no longer 
be transduced properly into functional signals for growth 
cone motility. 
The most striking of the KA and KC mutant phenotypes 
is that observed at stage 16 in the remarkable ability of the 
MP1 pathway to move back and forth across the midline 
freely. In wild-type embryos, the MP1 pathway never 
crosses the midline. These results suggest that normal 
Ca2+-CaM function is required in the growth cones of the 
MP1 pathway neurons in order for them to remain on their 
own side and to respect the putative repulsive signal at 
the midline (Seeger et al., 1993; Tear et al., 1993). 
In the developing CNS of the Drosophila embryo, the 
decision of whether growth cones cross the midline is 
tightly regulated. About 10% of the CNS interneurons proj- 
ect their axons only on their own side, in some cases ex- 
tending quite close to the midline and through commis- 
sural regions without crossing the midline (Tear et ai., 
1993). The other 90% of these CNS interneurons initially 
project their axons across the midline in one of the two 
major commissures and then turn either anteriorly or pos- 
teriorly in a particular longitudinal axon tract on the other 
side. The behavior of these growth cones after crossing 
the midline is markedly different from their behavior before 
reaching it: they typically show no affinity for the homolo- 
gous longitudinal pathway on their own side, but once they 
cross the midline, they change their behavior as they turn 
and follow the same pathway on the other side. Moreover, 
having crossed the midline, these growth cones rarely 
cross again, suggesting that they have either down- 
regulated their responsiveness to the putative midline at- 
tractant or up-regulated their responsiveness to the puta- 
tive repellent. 
Genetic analysis in Drosophila has revealed a few per- 
turbations that lead MP1 pathway growth cones to cross 
the midline abnormally, and several other genetic manipu- 
lations that alter the behavior of these same growth cones 
without causing them to cross the midline. For example, 
genetic manipulations that lead to the loss or failure to 
differentiate of certain midline cells can result in MP1 path- 
way axons incorrectly crossing the midline (Kl&mbt et al., 
1991; Menne and Kl&mbt, 1994), but these midline cells 
are clearly present and differentiate normally in KA and 
KC mutants; moreover, the ftzn~ element does not drive 
expression in these cells. 
The midline crossing of axons is not simply a secondary 
consequence of the failure of dMP2 to defasciculate from 
the vMP2 pathway. In separate studies, when the level of 
fasciclin II was increased selectively on these same growth 
cones and axons, dMP2 often failed to defasciculate from 
the vMP2 pathway at stage 13, and yet at stage 16, these 
abnormal pathways nevertheless clearly remained on 
their own side and did not cross the midline (Lin et al., 
1994). In another set of experiments, the same ftzng ele- 
ment was used to ablate these same neurons selectively 
using diphtheria toxin (D. Lin, V. Auld, and C. S. G., unpub- 
lished data). Large gaps and stalls in the formation of the 
MP1 pathway were observed at stage 13, and yet at stage 
16, the remaining MP1 pathway axons did not cross the 
midline. Thus, not every perturbation in these axons 
causes them to cross the midline. On the contrary, very 
few genetic manipulations cause these axons to cross the 
midline. 
The midline crossings of MP1 pathway axons in KA and 
KC mutant embryos are reminiscent of-the midline cross- 
ings observed at stage 16 in robo mutant embryos (Seeger 
et al., 1993). In robo, the pCC, vMP2, dMP2, and MP1 
growth cones cross the midline as soon as their growth 
cones reach the anterior commissure. The axons of many 
subsequent follower growth cones then also cross the mid- 
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line, and by s tage 16, the MP1 pathway crosses  the midl ine 
in many locat ions and appears  quite s imilar to what  we 
descr ibe  here in KA and KC mutant  embryos  (Figure 6; 
summar ized  in F igure 7). 
If indeed, as has been proposed  previously,  there are 
midl ine repuls ive s ignals  that  prevent  certain growth 
cones  from cross ing the midl ine ( rev iewed by Tear  et al., 
1993; Goodman,  1994), then there are apparent ly  two to- 
tal ly independent  genet ic  methods  of  overcoming  this mid- 
l ine repuls ion and al lowing the MP1 pathway axons  to 
cross  the midl ine, the first involving the loss-of- funct ion in 
the robo gene and the second involving the inhibit ion of  
Ca2÷-CaM s ignal ing in the growth cone. Prev ious studies 
on growth cone col lapse factors  in vitro have suggested  
that certain factors  may mediate  growth cone  col lapse 
v ia a Ca 2÷ s ignal ing mechan ism (Bandt low et al., 1993), 
whereas  others  may not (Ivins et al., 1991). The results 
descr ibed in the present  paper  suggest  that, in the devel-  
op ing CNS of  Drosophi la ,  at least one  type of putat ive 
midl ine repuls ive s ignal  that  prevents  MP1 pathway 
growth cones  f rom cross ing the midl ine may require nor- 
mal Ca2÷-CaM s ignal ing for its p roper  function. 
Experimental Procedures 
Construction of kinesin Fusion Proteins 
and Germ-Line Transformation 
The linker region between the kinesin and the ~-gal portions of the 
pKZtrap plasmid (Giniger et al, 1993) contained EcoRI, Smal, and 
BamHI restriction endonuclease sites as shown: GAT GCC AGA ATT 
CCC GGG GAT CCC (reading frame denoted in triplets). A 2 kb Notl- 
BamHI fragment was removed and ligated into pBluescript KS(+) to 
create pBS-kin encoding the kinesin motor domain (K). In this way, 
35 additional amino acids (from the CCC of the Smal site: GDPPA- 
AGLRYQAYRYRRPRGGARYAANSALVPISS) were added to the 
C-terminus of kinesin before a stop codon was read. For KA, the CaM 
regulatory domain of chicken MLCK was removed as a 0.170 kb 
BamHI-Sstl fragment from the bacterial expression vector pMK40K- 
Bam (Bagchi et al., 1992), blunt ended (mung bean nuclease), and 
ligated into the Sinai site of pBS-kin. A total of 44 amino acids were 
added to the C-terminus of kinesin: QKDTKNMEAKKLSKDRMKKY- 
MARRKWQKTGHAVRAIGRLSSQSQ (the CaM-binding domain is 
underlined). The KC transformant was created by removing the CaM 
coding sequence (148 amino acids) from pCaMPL as a 0.765 kb Ncol- 
Xbal fragment (VanBerkum and Means, 1991). The blunt-ended frag- 
ment (mung bean nuclease) was ligated into the Smal site of pBS-kin. 
Clones were sequenced to confirm the reading frame and the se- 
quence of the antagonist peptide, CaM, or the amino acid extension on 
K. The entire fusion protein was removed as a NotI-Asp-718 fragment, 
blunt ended (Klenow), and ligated into a blunt-ended (Klenow) Notl site 
of p2A/N-ftz-tx. This latter plasmid was created by blunt-end ligation of 
an approximately 1.5 kb Xbal-Xmnl fragment encoding the ftz,g ele- 
ment into the 5' Xbal site of the transformation vector pCASP 2A/N 
(provided by D. Lin). 
The construct encoding the CaM antagonist peptide alone (A) was 
created by removing the 0.17 kb BamHI-Sstl fragment of pMK40K 
and inserting it into pBluescript KS(+). A SstI-Smal fragment was then 
removed, blunt ended (T4 polymerase), and ligated into a blunt-ended 
Xbal site (Klenow) of pftzATG(lX). (pftzATG(lX) is a modified version 
of pftzN6ATG [provided by D. Van Vactor] such that the Xbal site at 
the 5' end of the ftz,~ element was removed by a partial Xbal digest, 
blunt ended, and religated.) In this way, the first 9 amino acids (MPAIV- 
LGGI) of HSP70 were added to the N-terminus of the CaM regulatory 
domain as found in pMK40K (or KA). The A minigene was removed 
from this kanamycin vector as an EcoRI fragment and inserted into 
the EcoRI sites of p2NNftz(tx). 
The p2NN-kinesin fusion plasmids were mixed in a 3:1 ratio with 
the helper plasmid pUChs~A2-3 (40 p.g/ml final concentration) and 
used to transform w "~8 embryos (Rubin and Spradling, 1982). Trans- 
formed flies were maintained in standard culture media as balanced 
stocks over CyO or TM3 balancers carrying a transposon encoding 
the lacZ gene under the regulation of the neural-specific elav promoter 
(elav-,8-gal). 
Immunocytochemistry 
Immunocytochemistry was performed using the previously described 
method (Kl~imbt et al., 1991), except we used 3.7% formaldehyde as 
the fixative. The MAbs 22C10, 1D4 (anti-fasciclin II; G. Helt, unpub- 
lished data), 3C10 (anti-even skipped), and 4D9 (anti-engrailed) were 
used at 1:5 dilutions. Horseradish peroxidase (HRP)-conjugated goat 
anti-mouse secondary antibody was used at a 1:400 dilution. Embryos 
carrying the elav-.8-gal transgene balancer chromosome(s) were iden- 
tiffed by X-gal activity staining for 2 hr at 37°C (Kl~mbt et a1.,1991). 
KA expression in embryos was determined using a rat MAb 10F4 (see 
below) diluted 1:1 and detected using the Vectastain ABC kit (Vector 
Laboratories). 
Antibody Production 
A synthetic peptide analog of the CaM regulatory domain, (C)EAKKL- 
SKDRMKKYMARRKWQKTGHAVRAIGRLSS, was synthesized by flu- 
orinylmethoxycarbonyl (FMOC) chemistry in an AB1431A synthesizer. 
The peptide was purified by reverse-phase high pressure liquid chro- 
matography and characterized by mass spectrometry (Hewlett- 
Packard 5989A), The peptide was conjugated to keyhole limpet hemo- 
cyanin using Sulfo-MBS (Pierce). Rats were injected, and once an 
immune response was detected, rat MAb 10F4 was isolated using 
standard techniques. 
Microtubule Co-Sedimentation 
Embryos were harvested and dechorinated as previously described 
(Saxton et al., 1988). After washing, embryos were transferred to test 
tubes on ice and rinsed twice with ice-cold PEM buffer (0.1 M Pipes [pH 
7.0], 5 mM EDTA, 2 mM MgSO,, 1 mM phenylmethylsulfonyl fluoride). 
Embryos were homogenized in 0.5-1.0 ml of PEM buffer plus addi- 
tional protease inhibiors (Saxton et al., 1988) for 60 s using a Brink- 
mann polytron. Homogenates were centrifuged at 20,000 x g for 20 
min (4°C), and the supernatants were again spun for 1 hr at 50,000 rpm 
in a TLA100.3 rotor (4°C). Microtubule polymerization was induced in 
the clarified supernatant by adding taxol (Sigma) and GTP to final 
concentrations of 20 ~.M and 1 mM, respectively (Saxton et al., 1988; 
Vale et al., 1985). After gentle agitation (40 rain at room temperature), 
AMP-PNP was added to 2.5 mM, and the samples were agitated for 
a further 30 min. Microtubules and associated proteins were sedi- 
mented at 50,000 rpm for 30 min (24°C), the pellets enriched for micro- 
tubules, kinesin, and the kinesin fusion proteins were resuspended 
in PEM, and SDS-sample buffer was immediately added. 
Western Blot Analysis 
Proteins in the microtubule-enriched pellets were separated by electro- 
phoresis on 8% SDS-polyacrylamide gels (O'Farrell, 1975) and trans- 
ferred to nitrocellulose by standard blotting techniques. Blots were 
probed with a 1:500 dilution of MAb DK410-2.1 (anti-Kinesin; provided 
by M. Sheetz), a 1:400 dilution of a mouse anti-~-gal, or a 1:10,000 
dilution of the rat serum antibody against the CaM-binding peptide. 
The HRP-conjugated goat anti-mouse or rat secondary was used (1 : 
15000), and the blot was developed by chemiluminescence (ECL; Am- 
ersham). To decrease background staining and remain in antibody 
excess, the blot was cut at the 100 kDa position, and each portion of 
the blot was probed and developed separately. 
CaM Overlay 
Bacterially expressed chicken CaM was purified as described else- 
where (VanBerkum and Means, 1991) and dialyzed overnight in 0.1 M 
phosphate buffer (pH 7.4). Succinimidyl D-biotin (1 raM; Molecular 
Probes) was crosslinked to CaM (1.2 mg/ml) for 2 hr at 4°C, and the 
reaction was terminated by extensive dialysis (C. Rasmussen, per- 
sonal communication). Replica Western blots were probed with 0.25 
pM biotinylated CaM in Trie-buffered saline, plus 10 mg/ml bovine 
serum albumin and either 4 mM CaCI2 or 8 rnM EDTA for 2 hr at room 
temperature. Bound CaM was detected by using HRP-conjugated 
streptavidin and developing the blots with diaminobenzidine. 
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